Gene therapy clinical trials in Belgium

Abstract

The present paper briefly describes the missing information about gene therapy clinical trials authorized in Belgium in relation with the regulatory framework. It also proposes a basic database format, complying with legal confidentiality rules. We then discuss transparency in the gene therapy field within the European Union.</p